Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT07302555
Recruiting Observational

Outcomes of Patients Over 75 Years of Age Who Consulted the Emergency Department for a Medical Problem

NCT07302555 · tracked via the Priya Life Science France tracker
Sponsor
University Hospital, Strasbourg, France
Phase
Observational
Started
2025-10-13
Last updated
2025-12-24

Condition(s) studied

Acute Medical Problem

Study summary

The increasing activity of emergency departments, coupled with a decrease in the number of hospital beds, is leading to operational changes, of which the Short-Stay Unit (UHCD) is one example. Initially designed for stays of less than 24 hours, it now finds itself providing supplementary hospitalization for downstream services, which is detrimental to the most vulnerable elderly patients.

Eligibility

Sex
ALL
Min age
75 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient aged ≥ 75 years * Patient admitted to the Strasbourg Emergency Department (Hautepierre and NHC) during 2019 for an acute medical problem * Patient with an indication for hospitalization in a conventional medical ward Exclusion Criteria: * Patient who died during their visit to the Emergency Department prior to hospitalization * Patient admitted for a scheduled hospitalization * Patient not requiring hospitalization in a conventional medical ward (either discharged home after the Emergency Department visit or admitted to intensive care) * Patient admitted to the Emergency Department for a surgical condition

Primary outcome measure(s)

  • 3-month mortality rate depending on whether or not they were hospitalized in the UHCD. — 3-month mortality rate after hospitalization

Trial sites (1)

FacilityCityRegionStatus
Service de Soins de Soins Médicaux et de Réadaptation - Réanimation - CHU de Strasbourg - France Strasbourg France Recruiting

More University Hospital, Strasbourg, France trials in France

The Interest of Systematic Screening for Dengue, Chikungunya, and Zika, in Malaria-negative Return Travelers Active, not recruiting
Dynamical Electrophysiology and Neuropathology in Lewy's Bodies Disease Recruiting
Impact of Perioperative Organ Resuscitation of Brain-dead Deceased Organ Donor on Kidney Graft Function in the Recipient Recruiting
Description of a Retrospective Cohort of Patients With Transthyretin Cardiac Amyloidosis (ATTR-CA) in Internal Medicine Recruiting
Study of the Care Pathway of Patients Admitted to the Palliative Care Unit of Strasbourg University Hospital From Their Home in 2025 Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07302555 on ClinicalTrials.gov ↗ ← All trials in France